3543-73-5 Ethyl 4-(5-Amino-1-Methyl-1H-Benzimidazol-2-yl) Butanoate 98%
Price | Get Latest Price | ||||
Packge | 1MT | 1kg | 5kg | 10kg | 25kg |
- Min. Order:1MT
- Time:2023-11-16
Product Details
- Product NameEthyl 4-(5-Amino-1-Methyl-1H-Benzimidazol-2-yl) Butanoate
- CAS No.3543-73-5
- EINECS No.680-673-0
- MFC14H19N3O2
- MW261.32
- AppearanceSolidOff-White to Pale Beige
- Melting point 130-135°C
- Boiling point 471.6±25.0 °C(Predicted)
- density 1.21±0.1 g/cm3(Predicted)
- storage temp. under inert gas (nitrogen or Argon) at 2–8 °C
Company Profile Introduction
Lorven Therapeutics Private Limited (LTPL) is a Private Limited Indian Non-Government Company incorporated in India on 18 October 2017 (Seven years 15 days old ). Its registered office is in Srikakulam, Andhra Pradesh, India.
The Company is engaged in the Business Outsourcing Industry.
Manufacturer of a wide range of products which include 6 Aminopyridine 2 Carboxylic Acid Methyl Ester, 2 3 Diamino 5 Bromopyridine, 5 Bromo 2 Chloro 4 Methylpyridine, 5 Bromo 2 Cyanopyridine and 2 Chloro 3 Methyl 5 Bromo Pyridine.
Offering you a complete choice of products which include Pyrazine hydrochloride, 4-Hydroxy Pyridine,5 Hydroxy 2 Methylpyridine, 3 Chloro 2 Methylpyridine, 2 Chloro 3 Iodo 4 Amino Pyridine, 3 Chloro 2 Picolinic Acid and 2 3 Dibromo 4 Methyl Pyridine.
Directors of Lorven Therapeutics are THAKASI VIJAYA KUMAR, VENKATARAMANA MUDILI ., RAHUL KUMAR PERAKA and LAXMINARAYANA VANAPARTHI.
Lorven Therapeutics' Corporate Identification Number (CIN) is U24110AP2017PTC106873 and its registration number is 106873. Users may contact Lorven Therapeutics on its Email address - ramana.micro@gmail.com. Registered address of Lorven Therapeutics is Modugulapeta Village Govindapuram Post, Santhakavitri Mandal , Srikakulam, Andhra Pradesh, India - 532123.
Recommended supplier
-
VIP1年
- Vepan Pharmatech Pvt Ltd
- 1-Methyl-5-amino-1H-benzimidazole-2-butanoic Acid Ethyl Ester
- Inquiry
- 2024-09-17
-
VIP1年
- Aspen Biopharma Labs Pvt Ltd
- 3543-73-5 Ethyl 4-(5-amino-1-methyl-1H-benzoimidazol-2-yl)-butyrate 98%
- Inquiry
- 2024-03-16
-
VIP1年
- Sibram Pharmaceutical
- Ethyl 4-(5-amino-1-methyl-1H-benzoimidazol-2-yl)-butyrate 99%
- Inquiry
- 2024-03-16
- Since:2020-11-02
- Address: Hyderabad, Telanagana